Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The purpose of this study is to determine the efficacy and safety of multiple CSJ117 doses (0.5; 1; 2; 4 and 8 mg) inhaled once daily compared with placebo, when added to standard-of-care (SoC) asthma therapy in adult patients with uncontrolled asthma with respect to change from baseline in FEV1 at the end of 12 weeks of treatment.
Epistemonikos ID: 28c04c154c6cb66d599df615273f582f32fab7bf
First added on: May 07, 2024